CPT 0401U: CARDIO inCodeScore Genetic Risk Assessment for Coronary Heart Disease

CPT code 0401U designates a Proprietary Laboratory Analyses (PLA) test for the CARDIO inCodeScore (CICSCORE) assay from GENinCode U.S. Inc., a genetic risk assessment that evaluates 12 variants in nine genes associated with coronary heart disease (CHD) using blood, saliva, or buccal swab specimens. As a PLA code, 0401U applies exclusively to this manufacturer-specific test and signals payers and providers that the service is a targeted molecular diagnostic for CHD risk stratification.

Key national payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coverage and reimbursement context for proprietary genetic tests, common billing considerations for PLA codes, and clinical context on how a multigene variant panel is used in CHD risk assessment. The publication presents benchmarks and policy-relevant updates applicable at the national level, clarifies typical sites of service and specimen types, and summarizes what documentation and coding practices matter for accurate claim submission.

This summary is intended for clinicians, laboratory managers, and revenue cycle professionals seeking a concise reference on the clinical purpose, payer landscape, and administrative considerations associated with CPT code 0401U.

Billing Code Overview

CPT code 0401U is a Proprietary Laboratory Analyses (PLA) code for the CARDIO inCodeScore (CICSCORE) test from GENinCode U.S. Inc. The assay evaluates 12 variants across nine genes associated with risk of coronary heart disease (CHD) using a blood, saliva, or buccal (cheek) swab specimen. This PLA code applies only to this specific manufacturer’s test and is therefore reportable solely for that proprietary assay.

Service Type: Genetic/Proprietary Laboratory Test (molecular/genetic risk assessment)

Typical Site of Service: Clinical laboratory or outpatient collection sites (blood draw centers, phlebotomy stations, clinic offices for saliva or buccal swab collection).

Clinical Context

A 52-year-old patient with a family history of premature coronary heart disease presents to a primary care clinic for cardiovascular risk assessment. The clinician orders the CARDIO inCodeScore (0401U) genetic risk test to evaluate inherited variants associated with coronary heart disease using a blood, saliva, or buccal swab specimen. The specimen is collected in the outpatient clinic or a phlebotomy lab and shipped to the performing laboratory (GENinCode U.S. Inc.). Results return as a risk score summarizing 12 variants across nine genes; the clinician integrates the report with traditional risk factors (lipid panel, blood pressure, smoking status, diabetes history) to inform risk communication and potential preventive strategies. Typical sites of service include outpatient physician offices, ambulatory surgery centers for specimen collection if bundled with other services, hospital outpatient labs, and independent clinical reference laboratories. The service type is a Proprietary Laboratory Analysis (PLA) molecular diagnostic test.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier; standard reporting	Use when no special circumstances apply to the service.
`22`

Taxonomy Code	Specialty	Notes
207Q00000X	Clinical Molecular Genetics	Laboratory directors and molecular geneticists who oversee PLA testing and interpretation.
207L00000X	Clinical Pathology	Pathologists who direct clinical laboratory operations and sign out molecular test reports.
363LP0800X	Genetics Counselor	Genetic counselors who provide pre- and post-test counseling for genetic risk testing.
207K00000X	Cardiology	Cardiologists who order and interpret results in the context of cardiovascular risk management.
207R00000X	Internal Medicine	Primary care physicians who order the test for preventive cardiovascular risk assessment.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I25.10`	Atherosclerotic heart disease of native coronary artery without angina pectoris	Genetic risk testing informs long-term risk stratification for coronary atherosclerosis.
`Z13.6`	Encounter for screening for cardiovascular disorders	Direct indication for a genetic risk score used in preventive screening.
`E78.5`	Hyperlipidemia, unspecified	Common comorbidity where genetic risk information complements lipid management decisions.
`I10`	Essential (primary) hypertension	Hypertension is a major cardiovascular risk factor evaluated alongside genetic risk.
`Z82.49`	Family history of ischemic heart disease and other diseases of the circulatory system	Family history often prompts genetic risk testing such as the CARDIO inCodeScore.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80061`	Lipid panel	Performed alongside genetic risk testing to assess traditional cholesterol-based risk factors that complement the CARDIO inCodeScore.
`36415`	Collection of venous blood by venipuncture	Common specimen collection procedure when a blood sample is used for the `0401U` PLA test.
`0001U`	Proprietary laboratory test (example of PLA format)	Other PLA-format molecular assays may be ordered in parallel; included as a representative PLA workflow item.
`G0318`	Collection of a specimen for molecular pathology (e.g., buccal swab)	Procedure codes for non-venous specimen collection such as buccal or saliva collection used for `0401U`.
`80306`	Pharmacogenetic testing (e.g., CYP2C19)	Other genetic tests that may be ordered in cardiovascular care to inform therapy decisions; often performed in the same lab workflow.

OpenPayer

Summary & Overview